PNC Financial Services Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
PGA
TF
PNC Financial Services Group's IDNA Position: Q2 2026 in Review
PNC Financial Services Group held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q2 2026 at 550 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3817.
PNC Financial Services Group first reported a position in IDNA in Q1 2021 and has held it in 22 quarters since. The position peaked at $62K in Q3 2021. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.
- PNC Financial Services Group held 550 shares of iShares Genomics Immunology and Healthcare ETF worth $18.6K as of Q2 2026.
- PNC Financial Services Group left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q2 2026.
- iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3817 holding.
- PNC Financial Services Group first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2021 and has held it in 22 quarters since.
- PNC Financial Services Group's iShares Genomics Immunology and Healthcare ETF position peaked at $62K in Q3 2021.
- 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.